The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts by Brunner, Jorg et al.
RESEARCH ARTICLE Open Access
The capsule of Porphyromonas gingivalis reduces
the immune response of human gingival
fibroblasts
Jorg Brunner
1, Nina Scheres
1, Nawal B El Idrissi
1, Dong M Deng
1, Marja L Laine
1, Arie J van Winkelhoff
2,
Wim Crielaard
1*
Abstract
Background: Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic
bacterium Porphyromonas gingivalis is considered a major causative agent. One of the virulence factors of P.
gingivalis is capsular polysaccharide (CPS). Non-encapsulated strains have been shown to be less virulent in mouse
models than encapsulated strains.
Results: To examine the role of the CPS in host-pathogen interactions we constructed an insertional isogenic P.
gingivalis knockout in the epimerase-coding gene epsC that is located at the end of the CPS biosynthesis locus.
This mutant was subsequently shown to be non-encapsulated. K1 capsule biosynthesis could be restored by in
trans expression of an intact epsC gene. We used the epsC mutant, the W83 wild type strain and the
complemented mutant to challenge human gingival fibroblasts to examine the immune response by quantification
of IL-1b, IL-6 and IL-8 transcription levels. For each of the cytokines significantly higher expression levels were found
when fibroblasts were challenged with the epsC mutant compared to those challenged with the W83 wild type,
ranging from two times higher for IL-1b to five times higher for IL-8.
Conclusions: These experiments provide the first evidence that P. gingivalis CPS acts as an interface between the
pathogen and the host that may reduce the host’s pro-inflammatory immune response. The higher virulence of
encapsulated strains may be caused by this phenomenon which enables the bacteria to evade the immune
system.
Background
Porphyromonas gingivalis is a major pathogen in
destructive periodontal diseases including chronic and
aggressive periodontitis that are characterized by break-
down of the tooth-supporting tissues [1-3]. P. gingivalis
is a black pigmented, often encapsulated, strict anaero-
bic, Gram negative coccobacillus that occurs in the
human oral cavity.
Among the variety of virulence factors that have been
described for P. gingivalis, CPS has shown to be a major
factor in experimental infections. Studies in a mouse
infection model have revealed that encapsulated P. gingi-
valis strains are more virulent than non-encapsulated
strains [4-7]. Non-encapsulated strains mostly cause
non-invasive, localized abscesses whereas encapsulated
strains cause invasive, spreading phlegmonous infections
after subcutaneous inoculation of experimental animals.
Six distinct capsular serotypes have currently been
described (K1-K6) [8,9] and a seventh serotype (K7) has
been suggested by R. E. Schifferle (personal communica-
tion). Small differences in virulence have been found
between capsular serotypes and strong variation in viru-
lence has been described between strains of the same
capsular serotype [10]. CPS of all serotypes has been
tested for induction of immunological responses in
macrophages and it has been revealed that the CPS of
K1 serotype strains induces higher chemokine expres-
sion in murine peritoneal macrophages than the other
serotypes [11]. These data suggest that the K1 CPS plays
an important role in host-pathogen interaction. The
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to a limited extent. It has been reported that the CPS of
K1 (strain W50) comprises of mannuronic acid (ManA),
glucuronic acid (GlcA), galacturonic acid (GalA), galac-
tose and N-acetylglucosamine (GlcNAc), but the CPS
structure has not been solved [12].
Although CPS is a major structure at the interface
between the bacterial cell and the host, the exact role of
P. gingivalis CPS is not yet clear. Adhesion to epithelial
cells has been shown to be higher for non-encapsulated
P. gingivalis and the level and mechanism of co-aggrega-
tion has been shown to be CPS dependent [5,13,14]. In
many pathogens CPS has been found to be involved in
evasion of the host immune system by circumvention of
phagocytosis, opsonization and complement killing
[15-17].
The aim of this study was to investigate in vitro differ-
ences in host response during infection with a wild type
and an isogenic non-encapsulated mutant of a naturally
encapsulated strain. The well-studied K1 serotype W83
strain was used as the wild type strain since its CPS bio-
synthesis locus has been described [18,19]. An inser-
tional mutation in PG0120 (epsC) was constructed,
which yielded a non-encapsulated strain. The gene has
been annotated as a UDP-GlcNAc 2-epimerase.
This epsC mutant is tested in a fibroblast infection
model [20] since fibroblasts are the most abundant stro-
mal cells in soft connective tissue of the gingiva [21]
and among the first cells encountering periodontal
infections by anaerobic bacteria like P. gingivalis.A n d
above all, fibroblasts have been shown to be involved in
the immune response in periodontitis [22,23]. Human
gingival fibroblasts were infected with W83 and the
epsC mutant and transcription of IL-1b, IL-6 and IL-8
was determined as host response parameters. This study
provides the first direct evidence that P. gingivalis CPS
reduces the host immune response, thereby potentially
enabling evasion of the immune system to sustain suc-
cessful long-term infection.
Results
EpsC mutant construction
After transformation of the linearized plasmid pΔEpsC
to P. gingivalis W83 the epsC insertional mutation was
confirmed by specific PCR amplifications and agarose
gel electrophoresis of the products (data not shown).
Primer combinations epsC BamHI F × PG0119 R and
EryF F × epsC EcoRI R (Table 1) ensured that a 1.2 Kb
fragment of pΔEpsC had been integrated by double
crossover at PG0120 (epsC) as expected, replacing the
intact copy with the insertionally inactivated copy
(Figure 1).
To examine if the mutation had an influence on the
growth characteristics of the epsC mutant both W83
and the epsC mutant were grown in brain heart infusion
broth supplemented with hemin (5 μg/ml) and mena-
dione (1 μg/ml) (BHI+H/M). Phase-contrast microscopy
revealed that the mutant grows in aggregates, but no
difference in growth rate was observed.
EpsC mutant characterization
The potential polar effect of the insertional inactivation
on the down stream gene of epsC named hup-1 was
examined. Total RNA was extracted from W83 and the
epsC mutant in the early exponential phase and the
hup-1 expression levels were evaluated by Real-Time
PCR. No significant difference in expression of hup-1
was found between W83 and the epsC mutant (data not
shown).
To show the effect of capsule-loss on the surface
structure of P. gingivalis the hydrophobicity of the epsC
mutant was tested by the capacity to adhere to hexade-
cane. While 3% of W83 cells was shown to adhere to
hexadecane more than 60% of the epsC mutant cells
was adhered to hexadecane. 19% of the complemented
mutant cells was adhered to hexadecane (see Additional
file 1).
Reactivity with the CPS-specific polyclonal rabbit anti-
sera against P. gingivalis serotypes K1-K6 [8,9] was
Table 1 Primers used in this study
Target Name Sequence (5’-3’)
epsC epsC
BamHI F
ATATAGGATCCATGAAAAAAGTGATGTTGGTC
epsC EcoRI
R
CTATGAATTCATCTTCGGCTAAATGCATCG
epsC AscI F GAATATAGGCGCGCCATGAAAAAAGTGATGTTGGTC
epsC SpeI CTATACTAGTATCTTCGGCTAAATGCATCG
eryF eryF ClaI F CCACCATCGATCGATAGCTTCCGCTATTGC
eryF ClaI R CCACCATCGATGTTTCCGCTCCATCGCCAATTTGC
CP25 CP25 ClaI F GCCATATCGATGCATGCGGATCCCATTATG
CP25 AscI R CCTTTAGGCGCGCCCTTAATTTCTCCTC
IL-6 IL-6 F GGCACTGGCAGAAAACAACC
IL-6 R GGCAAGTCTCCTCATTGAATCC
IL-8 IL-8 F GGCAGCCTTCCTGATTTCTG
IL-8 R CTGACACATCTAAGTTCTTCTTTAGCACTCCTT
IL-1b IL-1b F AAGATTCAGGTTTACTCACGTC
IL-1b R TGATGCTGCTTACATGTCTCG
hup-1 hup-1 F GAAAAGGCCAACCTCACAAA
hup-1 F TCCGATGAGAGCGATTTTCT
glk glk F ATGAATCCGATCCGCCACCAC
glk R GCCTCCCATCCCAAAGCACT
In bold: restriction sites used in this study
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mutant was not recognized by any of the antisera
including the K1 antiserum, whereas the wild type strain
was only recognized by the K1 antiserum (Figure 2).
Differences in CPS characteristics were also studied by
Percoll density gradient centrifugation, which can reveal
density differences between encapsulated and non-
encapsulted bacteroides strains [24]. Percoll density gra-
dient centrifugation analyses of W83 and the epsC
mutant showed that the density of the mutant had been
changed (Figure 3). Where W83 mostly settled at the
20-30% interface, the epsC mutant settled at the 50-60%
interface. Note that the appearance of W83 is diffuse
and not restricted to the 20-30% interface. The mutant
settles as a compact and granulous layer.
To conclusively examine the absence of CPS in the
epsC mutant, light microscopy was performed using
India ink in combination with fuchsine staining (Figure
4). The negative India ink staining allows direct visuali-
zation of the capsule, appearing as a light halo sur-
rounding the P. gingivalis cell. Fuchsine is used to stain
t h ec e l lb o d y .T h eh a l o sa r o u n dt h eW 8 3w i l dt y p e
s t r a i na r ec l e a r l yv i s i b l ei nt h ep h a s ec o n t r a s tm i c r o -
scopic picture, whereas halos are absent around the
epsC mutant. The intact epsC gene in trans under con-
trol of the CP25 promoter rescues the wild-type pheno-
type enabling the complemented mutant to produce a
K1 capsule again (Figures 2 and 4).
Fibroblast response to P. gingivalis challenge
To study the effect of the epsC deletion on the host
immune response six hour infection studies of human
gingival fibroblasts with W83 and the epsC mutant were
performed. Figure 5 shows IL-1b, IL-6 and IL-8 expres-
sion of infected gingival fibroblasts relative to the non-
infected negative control which is set to 1 and normal-
ized against expression of housekeeping gene GAPDH.
At multiplicity of infection (MOI) 1000:1 of both
strains a small induction of the tested genes could be
detected compared to the non-infected control, but sig-
nificant induction for all three genes was found when
MOI 10.000:1 was used for infection.At MOI 1000:1 IL-
6 and IL-8 expression showed a significantly higher
induction (150-fold and 37-fold induction respectively)
in the cells challenged with the epsC mutant when com-
p a r e dt ot h ew i l d - t y p e( 6 - f o l da n d2 - f o l di n d u c t i o n
respectively), IL-1b did not show a difference compared
to the wild-type. However, when gingival fibroblasts
were challenged with MOI 10.000 bacteria all three
tested genes showed a significantly higher induction in
the cells challenged with the epsC mutant than with
W83 (figure 5). When fibroblasts were challenged with
the complemented mutant the response was almost
completely restored to wild-type levels (see Additional
file 2).
Sedimentation of the epsC mutant in comparison to
W83 was analyzed in the same buffer as used in the
infection experiments. No significant sedimentation
Figure 1 Schematic representation of the knockout strategy to construct the epsC insertional mutation in W83. A. The genetic
arrangement of the 3’-end of the CPS locus in the W83 wild type strain with the grey rectangles representing the genes present. B. Construct
pΔepsC for insertional inactivation of epsC. The 1.2 Kb epsC was inserted into BamHI-EcoRI digested pGEX-6-p3 (oval) and interrupted by insertion
of a 1.2 Kb EryF (shaded rectangle) in the single ClaI restriction site present. The dashed lines between A and B show the homologous crossover
regions between the plasmid and W83 CPS locus. C. The final arrangement of the 3’-end of the P. gingivalis CPS locus after double crossover
showing the insertional inactivation of epsC. Arrows represent the primers used to confirm the integrity of the epsC mutant.
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mutant within the 6 hours needed for infection of the
fibroblasts (data not shown).
Since infections were done with viable P. gingivalis,
survival of the bacteria during the 6-hour aerobic period
of infection in DMEM medium had to be ensured.
Therefore a 6-hour survival experiment was performed
in the 24-well plates used for the fibroblast challenge.
On average 60-75% of W83, epsC mutant and comple-
mented mutant cells survived for 6 hours in Dulbecco’s
modified Eagle’s Medium (DMEM; Sigma Chemical Co.)
supplemented with 10% fetal calf serum (FCS) (see
Additional file 3).
Discussion
The aim of this paper was to understand the role of P.
gingivalis CPS in the response of human gingival fibro-
blasts.P. gingivalis CPS has been regarded as an impor-
tant virulence factor. It has been shown to induce
inflammatory mediators in in vitro studies [11]. The
capsule also plays an important role in shielding of
immune response inducers in several bacterial species
[25-27]. Since a distinct CPS biosynthesis locus in P.
gingivalis has been described and shown to be functional
[18,19], studying the role of P. gingivalis CPS in the
immune response by use of a mutant became feasible.
For this purpose an insertional isogenic knockout in
epsC, a potential capsular biosynthesis gene within the
CPS biosynthesis locus present in strains of different
serotypes, was constructed to prevent capsule synthesis.
The homologue of this gene in Listeria monocytogenes
lmo2537 has been shown to be essential for survival,
and has been suggested to be involved in the mainte-
nance of cell shape by providing a precursor of the tei-
choic acid linkage unit that serves as an acceptor for the
main teichoic acid chain assembly [28]. Construction of
the P. gingivalis epsC mutant shows that the epsC gene
is not essential for P. gingivalis viability.
In the present study the mutant is shown to be non-
encapsulated by double immuno-diffusion, density gradi-
ent centrifugation and India ink staining. Complementa-
tion resulted in rescue of wild-type K1 capsule
biosynthesis. Although the exact role of epsC remains to
be elucidated, this finding provides evidence that EpsC
is essential in P. gingivalis CPS biosynthesis.
The epsC mutant was expected to have altered immu-
nological properties. To examine the role of CPS, both
the wild-type and the epsC mutant were used in an in
vitro challenge of primary human gingival fibroblasts.
Since the epsC mutant has altered physical properties, it
was important to compare the sedimentation rate and
viability of both the wild type and the mutant strain
since these could have influenced the amount of living
bacterial cells that are in contact with the fibroblasts.
Figure 2 Double immunodiffusion analysis of autoclaved supernatants of P. gingivalis strains. Samples of W83, the epsC mutant and the
complemented mutant were tested against the K1-specific antiserum (central well). Note that the white precipitate indicating recognition of CPS
with the antiserum is absent in case of the epsC mutant, whereas the intact epsC copy restores the wild-type K1 antiserum recognition in the
complemented mutant.
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the 6 hours of infection.
From the infection experiments of the gingival fibro-
blasts it became apparent that pro-inflammatory media-
tors IL-1b, IL-6 and IL-8 expression levels were up-
regulated after a 6-hour challenge with both wild-type
W83 and the epsC mutant in comparison to the non-
infected control, especially when MOIs of 10.000:1 were
used.
A challenge with the epsC mutant induced a signifi-
cantly higher pro-inflammatory immune response than a
challenge with the wild type W83, as shown by IL-1b,
IL-6 and IL-8 gene expression. So, even though purified
P. gingivalis CPS has been shown to stimulate pro-
inflammatory cytokine expression in murine peritoneal
macrophages [11] the absence of capsule induces extra
cytokine induction when viable P. gingivalis cells were
used to challenge fibroblasts.
Capsular polysaccharides of several bacteria have been
implicated in down-regulation of pro-inflammatory cyto-
kine production, including Klebsiella pneumonia [29].
Bacteroides fragilis capsular polysaccharide complex has
been shown to induce IL-10 expression, a regulating
cytokine which may cause suppression of the immune
system [30].
An explanation of our results may be that the CPS
prevents more potent immune inducers to be recog-
nized by Toll-like receptors on the fibroblasts. It has
been shown that the capsular antigen in Salmonella
typhi, referred to as Vi-antigen, is able to prevent Toll-
like receptor 4 recognition of LPS, thereby reducing
expression of pro-inflammatory TNF-a and IL-6
[31-33]. In E. coli the capsule may cover short (10 nm)
bacterial adhesins, which do not penetrate the 0.2-1.0
μm capsular layer, preventing them from being recog-
nized by the immune system [26]. Likewise, P. gingivalis
strain W83 was described as to have a small amount of
Figure 3 Percoll density gradient centrifugation of W83 and epsC mutant. 1 ml of a OD690 = 4 suspension of overnight-grown P. gingivalis
was layered on top of a stepwise Percoll gradient (10-80%) and centrifuged at 8000 × g for one hour. The gradient is visualized using fuchsine-
stained layers in the marker (M).W83 reproducibly settles in the interfaces of 10-20%, 20-30% and 30-40% where most of the bacterial material is
found in the 20-30% interface. The epsC mutant settles as a distinct, granulous band at the 50-60% interface.
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Page 5 of 11Figure 4 Negative capsule staining of fuchsine-stained P. gingivalis cells with India Ink. Phase contrast microscopic picture at a 1000×
magnification of (A) W83 wild type strain, (B) epsC mutant and (C) the complemented epsC mutant in an India ink preparation which reveals the
capsule as a white halo (arrow). The inset shows an extra six times magnification.
Figure 5 Relative expression of IL-1b, IL-6 and IL-8 genes in human gingival fibroblasts (HGF1) infected with P. gingivalis W83 and the
epsC mutant. After a 6-hour challenge with P. gingivalis cells at MOI 1000:1 or 10.000:1 as indicated on the Y-axis, the expression levels of IL-1b,
IL-6 and IL-8 in human gingival fibroblasts were measured using RT-PCR and represented as a relative value compared to a non-infected control
sample which is set to a value of 1. Significant differences p < 0.01 are indicated by an asterisk.
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[34].
Another or additional explanation of our findings
could be immune suppression by P. gingivalis CPS,
meaning that CPS would actively modulate the immune
response of the fibroblasts, leading to lower inflamma-
tory cytokine expression levels, potentially enabling P.
gingivalis to evade the immune system.
For several bacteria it has been described that capsular
biosynthesis can be modulated depending on environ-
mental conditions [35,36]. Although presently no regula-
tion of P. gingivalis capsule expression has been
described, we can not exclude the possibility that in the
in vivo situation capsule expression is regulated. How-
ever, the reduced pro-inflammatory host’s immune
response by the encapsulated strain may explain the
documented differences between natural P. gingivalis
strains in spreading. Whereas non-encapsulated strains
are tackled directly by the immune system in localized
abscesses, the more virulent encapsulated strains can
evade this defence and cause phlegmonous infections
[4-7].
Conclusions
The epimerase-coding gene epsC of P. gingivalis is
essential for CPS synthesis. The absence of CPS results
in increased induction of IL-1b, IL-6 and IL-8 in human
gingival fibroblasts upon in vitro infection with viable P.
gingivalis cells. P. gingivalis CPS acts as a functional
interface between the pathogen and the host. The CPS-
related reduced pro-inflammatory response can explain
why natural non-encapsulated strains cause localized
abscesses and encapsulated strains spreading phlegmo-
nous infections.
Methods
Bacterial maintenance
P. gingivalis strains were grown either on 5% horse
blood agar plates (Oxoid no. 2, Basingstoke, UK) supple-
mented with hemin (5 μg/ml) and menadione (1 μg/ml)
(BA+H/M plates) or BHI+H/M, both, at 37°C in an
anaerobic atmosphere of 80% N2,1 0 %H 2,a n d1 0 %
CO2. Mutants were selected in the presence of 5 μg/ml
erythromycin. Complemented mutants were selected in
the presence of 50 μg/ml gentamycin and 1 μg/ml tetra-
cycline. Purity of P. gingivalis liquid and plate-grown
cultures was routinely checked by gram staining and
microscopic examination.
Escherichia coli DH5a was used for maintenance and
construction of plasmids. DH5a was cultured in Luria-
Bertani (LB) broth or on solid medium (LB broth with
addition of 1.5% agar). Ampicillin (Na
+ salt; 100 μg/ml)
was added to the growth media to select for pUC-
derived plasmids. E. coli S17-1 grown on LB
supplemented with 5 μg/ml tetracycline carrying the
complementation construct pT-PG0120 was used for
conjugation with P. gingivalis.
Human gingival fibroblasts
The gingival fibroblasts (HG F 1a n dH G F 2 )u s e di nt h i s
study were collected from extracted third molars of two
periodontally healthy subjects with a high pro-inflamma-
tory immunological response when challenged with P.
gingivalis [20]. Donors had given written informed con-
sent, and the study was approved by the VUmc Medical
Ethical committee.
Genomic DNA isolation from P. gingivalis
Genomic DNA from P. gingivalis strains was isolated
from plate-grown bacteria using the DNeasy tissue kit
(Qiagen Benelux BV). The DNA concentration of all
samples after purification was between 20 ng/μla n d6 0
ng/μl.
Generation of an insertional knockout construct for epsC
To make an insertional knockout of epsC in the W83
wild type strain we constructed plasmid pΔEpsC. Pri-
mers epsC BamHI-F and epsC EcoRI-R (see table 1 for
details) were used to amplify the 1.2 Kb epsC gene from
P. gingivalis W83 genomic DNA in a PCR reaction. Pfu
polymerase (Fermentas, GmbH, St. Leon-Rot, Germany)
was used according to the manufacturer’sp r o t o c o lw i t h
100 ng of genomic DNA. The PCR program started
with 95°C for 5 min and then 25 cycles of 95°C, 55°C
and 72°C for 30 s, 30 s and 2.5 min respectively and
was ended by one step of 72°C for 5 min. The amplified
fragment was cleaned using the Qiagen PCR purification
kit (Qiagen Benelux B.V.) and restricted with BamHI
and EcoRI. This restricted epsC gene fragment was
ligated into BamHI-EcoRI restricted pGEX-6p-3 plasmid
to yield pGEX-PG0120.
The 1.2 Kb EryF erythromycin resistance cassettes for
use in P. gingivalis was amplified from plasmid pEP4351
using primers EryF ClaI F and EryF ClaI R. and after
restriction with ClaI this fragment was ligated into the
ClaI-restricted pGEX-PG0120 plasmid yielding pΔEpsC.
The ScaI-linearized pΔEpsC plasmid was used for inser-
tional inactivation of epsC in P. gingivalis strain W83.
Complementation of the epsC mutant
The 120 bp artificial constitutive CP25 promoter [37]
was amplified from plasmid pDM15 [38] using primers
CP25 ClaI F and CP25 AscI R. The intact epsC 1.2 Kb
gene was amplified from genomic DNA of P. gingivalis
strain W83 using primers epsC AscI F and epsC SpeI R.
After ligation of these fragments into cloning vector
pJET1.2 (Fermentas, GmbH, St. Leon-Rot, Germany) the
constructed expression cassette was cut out with XhoI
and HindIII and ligated into the SalIa n dHindIII
digested pT-COW shuttle plasmid [39] to yield the
complementation construct pT-PG0120.
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BHI+H/M was inoculated with P. gingivalis W83 from a
6-day-old blood agar plate. This pre-culture was anaero-
bically incubated at 37°C for 2 days. 2 ml of the pre-cul-
ture was used to inoculate a 100 ml culture. The next
day this culture was used to inoculate 2 × 100 ml of
fresh BHI+H/M to an OD690 of 0.2. After six hours of
anaerobic incubation at 37°C the cells were harvested by
centrifugation in mid-exponential phase. The pellet was
washed two times in 20 ml EPB (10% glycerol, 1 mM
MgCl2) and after that resuspended in 2 ml of EPB. Ali-
quots of 200 μlw e r es t o r e da t- 8 0 ° Ca n du s e df o r
electroporation.
200 ng of PstId i g e s t e dp ΔEpsC was added to 200 μl
of W83 P. gingivalis cells. The mixture was transferred
to a 2 mm electroporation cuvette and electroporated
using an Electro Cell Manipulator 600 (BTX Instrument
Division, Holliston, MA, USA; 25 μF, 2.5 kV, 186 Ω). 1
ml of BHI+H/M was added immediately after the pulse.
The cells were left for recovery anaerobically at 37°C for
18 hours. The suspension was plated on BA+H/M plates
with 5 μg/ml erythromycin for selection of the transfor-
mants. The authenticity of the insertional knockout
epsC mutants was verified using primer combinations
e p s CB a m H IF×P G 0 1 1 9Ra n dE r y FC l a IF×e p s C
E c o R IR .F u r t h e r m o r e ,u s i n gR e a l - T i m eP C R ,t h e
expression of the downstream gene hup-1 in both W83
and the epsC mutant was monitored using primers hup-
1 F and hup-1 R to exclude polar effects. W83 and the
epsC mutant were grown till early exponential phase.
The cell pellets were collected by centrifugation and
resuspended in RLT buffer (Qiagen, Benelux B. V.). The
cells were disrupted using a Fast Prep Cell Disrupter
(Bio 101, Thermo electron corporation, Milford, USA)
and centrifuged, the total RNA was extracted from the
supernatant according to the manufacturer’sp r o t o c o lo f
Qiagen RNeasy® mini kit (Qiagen Benelux B.V.). The
residual contaminating genomic DNA was removed by
Turbo DNA-free™ kit (Ambion, Austin, USA). mRNA
was then reverse transcribed using the Fermentas first-
strand cDNA synthesis kit (Fermentas GmbH, St. Leon-
Rot, Germany) according to the manufacturer’s protocol.
The synthesized cDNA was further analyzed using
Real-Time PCR with gene-specific primers on an ABI
Prism 7000 Sequence Detecting System (Applied Biosys-
tems, Nieuwerkerk a/d lJssel, The Netherlands). Gene
expression was normalized to the expression of glucoki-
nase (glk), amplified with primers glk F and glk R [40].
The relative hup-1 expression levels of W83 from three
independent experiments were compared in duplicate to
those of the epsC mutant.
Conjugation of P. gingivalis
To complement the epsC mutant, plasmid pT-PG0120
was transferred into the mutant by conjugation
following a protocol described earlier [41], with slight
modifications. For selection of P. gingivalis after the
over-night conjugation we used 50 μg/ml of gentamycin
in our blood agar plates instead of 150 μg/ml. Integrity
of the trans-conjugants was confirmed by colony PCR
and plasmid isolation combined with restriction analysis
using a plasmid isolation kit (Qiagen Benelux B.V.).
Percoll density gradient centrifugation
Percoll density gradients were in principle prepared as
described by Patrick and Reid [24]. In short, a 9:1 stock
solution of Percoll (Pharmacia, Biotech AB, Uppsala,
Sweden) was prepared with 1.5 M NaCl. Solutions con-
taining 80, 70, 60, 50, 40, 30, 20 and 10% Percoll in 0.15
NaCl were prepared from the stock. In an open top 14
ml polycarbonate tube (Kontron instruments, Milan,
Italy) 1.5 ml of each of the solutions was carefully
layered on top of the previous starting with 80%. 1 ml
of an anaerobically grown over night culture of wild
type and the epsC mutant concentrated to an OD690 of
4 in PBS was added to the top of the 10% layer and cen-
trifuged for one hour at 8000 × g at 20°C in a Centrikon
TST 41.14 rotor (Kontron instruments, Milan, Italy)
using a Centrikon T-1170 (Kontron instruments, Milan,
Italy) centrifuge.
Hydrophobicty of P. gingivalis
W83, the epsC mutant and the complemented mutant
were grown 18 hours in BHI+H/M. The bacteria were
washed twice in PBS after which the OD600 was set to
0.5. After addition of 150 μl n-hexadecane to 3 ml of
this suspension the mix was vortexed 30 seconds, rested
for 5 seconds and vortexed for 25 seconds. After exactly
10 minutes incubation at room temperature a sample
was taken to measure the OD600 of the aqueous phase.
The percentage of bacteria adhered to hexadecane was
calculated by the formula: (OD600 before-OD600 after)/
OD600 before × 100%. The presented data in Additional
figure 1 were collected from two experiments using tri-
plicate measurements.
P. gingivalis serotyping
Serotyping of P. gingivalis was based on the detection of
the six described K-antigens [8,9]. In short, serotype-
specific, polyclonal antisera were obtained after immuni-
zation of rabbits with whole bacterial cells of the six P.
gingivalis type strains [42]. Bacterial antigens for double
immunodiffusion tests were prepared as described pre-
viously [8]. Immunodiffusion was carried out in 1%
agarose (Sigma Chemical Co., St. Louis, MO, type 1, low
EEO) in 50 mM Tris-HCl buffer (pH 8.6). 10 μla n t i -
serum and 10 μl of antigen were loaded and allowed to
diffuse and precipitate for 48 hours at room
temperature.
India ink negative staining
P. gingivalis cells were taken from 4 day-old plates and
resuspended in 1 ml of PBS. On a glass slide 10 μlo f
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(Talens, Apeldoorn, The Netherlands) and using another
glass slide a thin film was made. The film was air-dried.
Ad r o po f0 . 2 %f u c h s i n ew a scarefully added onto the
film and removed after 2 minutes by decanting. Then
the film was air-dried. Pictures were taken with a Leica
DC500 camera on a Zeiss Axioskop using phase-
contrast.
Growth curve
Pre-cultures of W83 and the epsC mutant were grown
anaerobically for 18 hours in BHI+H/M at 37°C. The
pre-cultures were diluted to an OD690 of 0.05 in duplo
in fresh BHI+H/M and incubated anaerobically at 37°C.
Every few hours the OD690 was measured and a sample
was taken for cfu-counts.
Sedimentation of P. gingivalis
W83 and the epsC mutant were grown anaerobically for
18 hours in BHI+H/M at 37°C. After 3 wash steps in
phosphate buffered saline (PBS) the OD690 was standar-
dized to 5 in DMEM with 10% FCS. 10 ml of this cul-
ture was added to 40 ml DMEM with 10% FCS in a 100
ml flask to set the OD690 to 1. The cultures were incu-
bated standing still at 37°C for six hours. At regular
time intervals, a 200 μl sample was taken 0.5 cm from
the liquid surface and the decrease of the OD690 values
was determined as a measure for sedimentation.
Survival of P. gingivalis
W83, the epsC mutant and the complemented mutant
were grown anaerobically for 18 hours in BHI+H/M at
37°C. After 2 wash steps in phosphate buffered saline
(PBS) the pellets were resuspended in DMEM with 10%
FCS to an OD690 of 0.05 as used in fibroblast infections
at MOI 10.000:1. 500 μl of these suspensions was incu-
bated at 37°C in a humidified atmosphere of 5% CO2 in
air. Samples for cfu-counts were taken at t = 0 hours, t
= 3 hours and t = 6 hours and dilutions were plated on
BA+H/M plates.
Infection of gingival fibroblasts with P. gingivalis
Bacteria were grown overnight for 18 hours in BHI+H/
M. The bacterial cells were washed three times in PBS
and then used to infect gingival fibroblasts at MOIs of
1000:1 and 10.000:1 (bacteria cells: fibroblasts) in a total
volume of 500 μl DMEM with 10% FCS in 24-well
plates. The plates were incubated for 6 hours at 37°C in
a humidified atmosphere of 5% CO2 in air. The cells
were washed twice with cold PBS. Then 350 μl lysis buf-
fer (1% b-mercapthanol in RLT buffer) was added to the
cells according to the protocol of Qiagen RNeasy® mini
kit (Qiagen Benelux B.V.) after which the plate was
stored at -80°C for later use.
RNA isolation and reverse transcription
mRNA was isolated from the gingival fibroblast lysates
according to the manufacturer’sp r o t o c o lo fQ i a g e n
RNeasy® mini kit (Qiagen Benelux B.V.). The mRNA
concentrations of the samples were determined using
the Nanodrop ND_1000 (Isogen Life Science). mRNA
was reverse transcribed using the Fermentas first-strand
cDNA synthesis kit (Fermentas GmbH, St. Leon-Rot,
Germany) according to the manufacturer’s protocol.
Real-Time PCR
cDNA synthesized from mRNA isolated from gingival
fibroblasts after infection with P. gingivalis was analyzed
in quadruple using Real-Time PCR with gene-specific
primers on a ABI Prism 7000 Sequence Detecting Sys-
tem (Applied Biosystems, Nieuwerkerk a/d lJssel, The
Netherlands). Reactions were performed with 2 ng
cDNA in a total volume of 8 μl containing SYBR Green
PCR Master Mix (Applied Biosystems) and 0.99 pM of
each primer. After activation of the AmpliTaq Gold
DNA polymerase for 10 minutes at 94°C, 40 cycles were
run of a two step PCR consisting of a denaturation step
at 95°C for 30 seconds and annealing and extension step
at 60°C for 1 minute. Predicted product sizes were in
the 100-200 bp range. Subsequently the PCR products
were subjected to melting curve analysis to test if any
unspecific PCR products were generated. The PCR reac-
tions of the different amplicons had equal efficiencies.
Samples were normalized for the expression of house-
keeping gene GAPDH, which is not affected by the
experimental conditions, by calculating the Δ Ct (Ct
housekeeping gene -C tgene of interest) and expression of the
d i f f e r e n tg e n e si se x p r e s s e da s2
-(ΔCt).F o l di n c r e a s ei n
gene expression (induction) was expressed by 2
-(ΔΔCt),
wherein ΔΔCt = ΔCtchallenged-a v e r a g eC t - v a l u enon-
challenged.
Statistical analysis
Differences in gene induction between multiple groups
were tested by one-way analysis of variance (ANOVA)
and Bonferroni’s Multiple Comparison Test. Tests were
performed with GraphPad Prism version 4.00 for Win-
dows, GraphPad Software, San Diego California USA.
Differences were considered significant at p < 0.01.
Additional file 1: Hydrophobicity of P. gingivalis strains. Percentage
of bacterial cells adhered to hexadecane after extensive vortexing and 10
minutes incubation. 3.4%, 61% and 19% of the cells was adhered to
hexadecane for W83, the epsC mutant and the complemented mutant
respectively, indicating increased hydrophobicity for the epsC mutant.
The data are the averages of two experiments comprised of triplicate
measurements. The bars show the standard deviations.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2180-10-5-
S1.PNG]
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Page 9 of 11Additional file 2: Effect of complementation of the epsC mutant on
the immune response mutant of human gingival fibroblasts (HGF2).
After a 6-hour challenge with P. gingivalis cells at MOI 10.000:1, the
expression levels of IL-1b, IL-6 and IL-8 in human gingival fibroblasts were
measured using RT-PCR and if possible represented as a relative value
compared to a non-infected control sample which is set to a value of 1.
Relative IL-1b expression could not be calculated as IL-1b was not
detected in the non-infected control. Complementation almost restored
the wild-type situation for IL-1b (83%), IL-6 (83%) and IL-8 (77%).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2180-10-5-
S2.PNG]
Additional file 3: Six hour survival of W83, the epsC mutant and the
complemented mutant under aerobic experimental conditions.
Survival of W83, the epsC mutant and the complemented mutant in 0.5
ml DMEM + 10% FCS under humidified 5% CO2 conditions was
determined by cfu-counts on BA + H/M plates. Survival of 67%, 60 and
73% was found for each strain respectively. Error bars represent the
standard deviations of triplicate measurements.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2180-10-5-
S3.PNG]
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